Press launch MHRA approves GLP –one receptor agonist semaglutide to cut back threat of great heart troubles in obese or overweight Grownups Semaglutide is the initial fat reduction drug approved in the united kingdom for a preventative treatment method for anyone with recognized cardiovascular diseaseOrlistat is actually a tablet that's taken sim